p16INK4a/CDKN2A Antibody (CDKN2A/3830), HRP, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB382564-Each-of-1 | In Stock | ₹ 47,570.50 |
NB382564 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,570.50
GST (18%): ₹ 8,562.69
Total Price: ₹ 56,133.19
Antigen
p16INK4a/CDKN2A
Classification
Monoclonal
Conjugate
HRP
Gene Alias
ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16
Immunogen
Purified recombinant prokaryotic full-length human p16INK4a protein (Uniprot: P42771)
Quantity
100 μg
Research Discipline
ABC Transporters, Biologically Active Proteins, Cancer, Cell Cycle and Replication, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, Tumor Suppressors
Gene ID (Entrez)
1029
Content And Storage
Store at 4°C in the dark.
Isotype
IgG
Applications
Immunohistochemistry (Paraffin)
Clone
CDKN2A/3830
Formulation
PBS
Host Species
Mouse
Purification Method
Protein A or G purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- Description p16INK4a/CDKN2A Monoclonal antibody specifically detects p16INK4a/CDKN2A in Human samples
- It is validated for Immunohistochemistry (Paraffin)